Filing Details
- Accession Number:
- 0001209191-19-057692
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-21 20:49:04
- Reporting Period:
- 2019-11-19
- Accepted Time:
- 2019-11-21 20:49:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1763581 | Mark Schoenberg | C/O Urogen Pharma Ltd. 499 Park Avenue New York City NY 10022 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2019-11-19 | 1,960 | $28.17 | 7,967 | No | 4 | P | Indirect | By Mark Schoenberg Pension Plan FBO Mark Schoenberg |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Mark Schoenberg Pension Plan FBO Mark Schoenberg |